FTC on mergers
This article was originally published in The Tan Sheet
Executive Summary
"In determining whether to challenge a [merger] transaction, the agencies do not simply tally the number of customers that oppose a transaction and the [number] that support it," according to FTC and the Department of Justice. "The agencies take into account that all customers in a relevant market are not necessarily situated similarly in terms of their incentives," they state in the jointly published Commentary on the Horizontal Merger Guidelines, released March 27. The document provides insight into federal antitrust review of horizontal mergers between competing firms, the agencies say...
You may also be interested in...
FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility
The US FDA’s device center has unveiled a new public dataset designed to assist chemistry laboratories in ensuring the robustness of chemical characterization methods used to assess the biocompatibility of medical devices.
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.